Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 2

Status

Terminated 4Completed 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 4Breast 3CNS 2Tumor-Agnostic 1Sarcoma 1Other hematologic neoplasm 1Lymphoid 1Head & Neck 1Gastrointestinal 1Dermatologic 1

Conditions

Prostatic Neoplasms 3Neoplasm Metastasis 2Non Castrate Metastatic Prostate Cancer 1

Interventions

Docetaxel 69pembrolizumab 48Prednisone 43Nivolumab 40enzalutamide 38Gemcitabine 37Sunitinib 36Cyclophosphamide 29Radiotherapy 26Magnetic Resonance Spectroscopy 26Leuprolide 25Abiraterone Acetate 25Sorafenib 23Everolimus 23Cisplatin 23bicalutamide 19atezolizumab 18Carboplatin 18Bevacizumab 18avelumab 17Radiosurgery 17Goserelin 17Interleukin-2 16abiraterone 15fludarabine 14Doxorubicin 14olaparib 13durvalumab 13cabozantinib 13acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Terminated × NVP-BKM120 × Genitourinary × Clear all
NCT01695473 2021-01-13

Neoadjuvant BKM120 in High-risk Prostate Cancer

University of California, San Francisco

Phase 2 Terminated
11 enrolled 8 charts
Genitourinary

Prostatic Neoplasms

NCT01741753 2019-02-05

BKM120+Abiraterone Acetate for Metastatic CRPC

Dana-Farber Cancer Institute

Phase 1 Terminated
4 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT02487823 2017-11-17

NCMPC-BKM

Institut Paoli-Calmettes

Phase 1 Terminated
6 enrolled
Genitourinary

Non Castrate Metastatic Prostate Cancer

NCT01385293 2017-05-19

BKM120 in Metastatic Castration-resistant Prostate Cancer

Duke University

Phase 2 Terminated
30 enrolled 11 charts
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡